FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:1752-1753 April 20, 2006 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Iacono, A. T. PubMed Citation

To the Editor: The report by Iacono and colleagues (Jan. 12 issue)¹ on the effect of inhaled cyclosporine in lung-transplant recipients raises important questions that need further clarification. Although the authors found that inhaled cyclosporine reduced the two- and three-year prevalence of the bronchiolitis obliterans syndrome, as compared with placebo, it is very surprising in the modern era of lung transplantation to find such a high prevalence of this syndrome: about 70 and 65 percent after two and three years, respectively, in the treated group, on the basis of spirometry, as compared with 50 and 30 percent, respectively, in the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.